ovarian cancer
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2022/06/GettyImages-1144673320.jpg)
Mayo Clinic researchers are studying the cost-effectiveness of genomic research to detect certain diseases earlier, including breast, ovarian and colorectal cancer.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2022/04/GettyImages-1300319760.jpg)
Gynecologic surgeon Dr. Tri Dinh explains why ovarian cancer is hard to detect, options for reducing ovarian cancer risk, and how the disease is treated.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2021/12/GENOMICS-CANCER1-1-1536x943-1.jpg)
Mayo Clinic is sequencing the exomes of tens of thousands of people from diverse backgrounds to investigate large-scale patterns of distinctive mutations that fuel disease.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2021/01/shutterstock_212629813.jpg)
Physician assistant Casey Swanson responds to a question about cancer risk and genetic testing for a BRCA2 mutation.